Abstract
Copeptin is a non-specific marker of an endogenous stress response. A dual biomarker marker approach involving the simultaneous use of troponin and copeptin assays may assist early exclusion of acute coronary syndrome in Australian emergency departments. The utility and limitations of this approach are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 921-924 |
| Number of pages | 4 |
| Journal | Internal Medicine Journal |
| Volume | 44 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept 2014 |
| Externally published | Yes |
Keywords
- Acute coronary syndrome
- Arginine vasopressin precursor
- Copeptin
- Emergency department
- Myocardial infarction
- Troponin
Fingerprint
Dive into the research topics of 'Rapid rule out of myocardial infarction with the use of copeptin as a biomarker for cardiac injury'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver